Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy

The search for innovative anti-cancer drugs remains a challenge. Over the past three decades, antibodies have emerged as an essential asset in successful cancer therapy. The major obstacle in developing anti-cancer antibodies is the need for non-immunogenic antibodies against human antigens. This un...

Descripción completa

Detalles Bibliográficos
Autores principales: França, Renato Kaylan Alves, Studart, Igor Cabral, Bezerra, Marcus Rafael Lobo, Pontes, Larissa Queiroz, Barbosa, Antonio Marcos Aires, Brigido, Marcelo Macedo, Furtado, Gilvan Pessoa, Maranhão, Andréa Queiroz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536222/
https://www.ncbi.nlm.nih.gov/pubmed/37766309
http://dx.doi.org/10.3390/v15091903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536222/
https://www.ncbi.nlm.nih.gov/pubmed/37766309
http://dx.doi.org/10.3390/v15091903

Ejemplares similares